Weitere ähnliche Inhalte Ähnlich wie Role of Insurance for Innovative Technologies: Nanotechnology (20) Mehr von Fondazione Giannino Bassetti (20) Kürzlich hochgeladen (20) Role of Insurance for Innovative Technologies: Nanotechnology 1. Allianz Global Corporate & Specialty
Role of Insurance for
Innovative Technologies:
Nanotechnology
AGCS Risk Consulting /
Head of R&D, Michael Bruch /
Milano
27 November 2012
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 1
2. Table of
contents 1 Allianz and AGC&S
2 Emerging risk definition
3 What is nanotechnology and where is it used?
4 Opportunities and risks from an insurers
perspective
5 Risk assessment of nanorelated applications
6 What is needed to promote nanotechnologies in
as sustainable manner?
7 Outlook
2
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 2
3. Allianz
An Introduction
Allianz Group is one of the world’s leading insurers and financial
services providers
Founded in 1890 in Berlin, Allianz companies now extend to over 70
countries with approximately 142,000 employees and 78 million customers
Insurer financial strength rating of AA (‘Very Strong’) from S&P and A+
(‘Superior’) from A.M. Best
International network of strong brands,
with first-class products in the fields of:
1. property and casualty insurance
2. life and health insurance
3. asset management
For more information visit www.allianz.com.
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 3
4. Allianz SE Results 2011
In summary Revenues again surpass
Solid performance despite difficult environment
1 €100bn mark
Stable operating profit of €7.9bn, on target €1.8bn in NatCat claims paid
Revenues of €103.6bn, close to 2010’s record
2 or reserved for our customers
(€106.5bn)
Operating profit target
Net income of €2.8bn (2010: €5.2bn) impacted 3 achieved despite challenges
by impairments from Greek sovereign bonds
and financial sector investments Diversified business key to
P&C business: revenues increased to record 4 strength
high of €44.8bn - profitability also maintained
Excellent capital position with
L&H business remains on high level with €2.4bn
operating profit
5 strong solvency ratio
Asset Management delivers excellent result
Strong capital position further improved: “These results show the true
shareholders’ equity rose to €44.9bn, solvency strength of the Allianz business
ratio increased to 179% as at Dec 31 st 2011 model.“
Allianz SE maintains its strong financial ratings
Michael Diekmann, CEO of Allianz SE
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 4
5. Allianz Global Corporate & Specialty
An Overview
We are one of the few specialist corporate insurers with a genuine global market
presence who can provide “one carrier” insurance solutions across the whole
spectrum of corporate and specialty risks.
Product lines
Diversified product portfolio
Alternative Risk Transfer Aviation
Wide range of complementary services,
including specialist non-traditional risk transfer
solutions provided by our subsidiary ART Energy Engineering / Construction
Financial strength: €4.9 billion GWP (2011)
Financial Lines Global Programs
Global reach: integrated in the Allianz network
of more than 150 countries worldwide
Extensive international experience: manages Liability / Casualty Marine
some 1,600 International Insurance Programs
More than 3,400 dedicated employees Property Risk Consulting
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 5
6. Emerging risk definitions according to
CRO ERI members
Full nature and effects are not yet known
May develop or already exist
Difficult to quantify and may have a large
loss potential on society and industry
Represent potential business opportunities
for the insurance industry as well
Often they are already present in an insurers
existing portfolio.
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 66
7. Table of
contents 1 Allianz and AGC&S
2 Emerging risk definition
3 What is nanotechnology and where is it used?
4 Opportunities and risks from an insurers
perspective
5 Risk assessment of nanorelated applications
6 What is needed to promote nanotechnologies in
as sustainable manner?
7 Outlook
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 7
8. Examples of Emerging Risks….and their drivers
Innovation
Electromagnetic fields
Economy
Genetic modified organism
Power blackouts
Cyber risks
Endocrine disrupters
Nanotechnology
Obesity
Offshore Wind
Longevity
…
Legal framework
Society
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 8
9. © November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 9
10. Risk Assessment - Opportunities and Risks of Nanotechnologies
Joint Report with the International Future Program of
OECD in 2005
Contents:
What is nanotechnology?
Markets for nanotechnologies
Players
Government programs
Risks
Opportunities and Risks for the AZ Group
Press conferences in London, München,
Wien, Madrid
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 10
11. "Dosis facit venenum."
(Paracelsus, 1538)
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 11
12. Table of
contents 1 Allianz and AGC&S
2 Emerging risk definition
3 What is nanotechnology and where is it used?
4 Opportunities and risks from an insurers
perspective
5 Risk assessment of nanorelated applications
6 What is needed to promote nanotechnologies in
as sustainable manner?
7 Outlook
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 12
13. Sizes of various objects for comparison
Source: VDI TZ / Federal Ministry of Education and Research
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 13
14. New properties of engineered nanoparticles
Quantum-mechanic Increased surface area Molecular recognition
behaviour
„New“ technical physics „New“ chemical processes „New“ bio-applications
through changes in through changes in through combination with
Colour, transparency Melting and boiling Self-organisation
Hardness point Repairability
Magnetism Chemical reactivity Adaptability
Electrical conductivity Catalytic yield Recognition
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 14
15. What is Nanotechnology?
Nanotechnology is the understanding and control of matter at
dimensions of roughly 1 to 100 nanometers
Synthesis and Manipulation of matter in
Nano Scale Dimensions
Nanoparticles (e.g. Carbon Black)
Carbon nanotubes / fullerenes
Fullerene
Atomic Force Microscope
...
Materials with tailor-made new physical, chemical and
biological properties.
Sources: Universities of Reading,
Carbon Nanotube
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE Nagoya
15
16. Natural sources of nanoparticles
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 16
17. Consumer Nano-products
Source:
http://www.nanotechproject.org/
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 17
18. Nanoproduct figures 2011
Number of products according to main categories ( ∑ = 1,393)
Cross cutting applications (coatings) Appliances
Goods for Children 6% 3% (washing machine, air cleaners)
Electronics and Computers 2% 8%
4% Food & Beverage
(e.g. dietary supplement)
Home & Garden 15%
(cleaning supplies)
Automotive
(tires, lacquers) 9%
Health & Fitness
53% (sporting goods, clothing,
cosmetics, sunscreens)
Source: www.nanotechproject.org
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 18
19. Nanoproducts in the future
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 19
20. Ongoing industrial production of nanoparticles
Pyrogenic oxides
• Silica (1940´s)
• Surface-treated silica (1960´s)
• Alumina (1950´s)
• Titania (1950´s)
• Mixed metal oxides (1950‘s)
• Zirconia (1990´s)
• Zinc dioxide (2000´s)
Source: Dechema / VCI
Nanostructured materials are not new
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 20
21. Zinc oxide for UV-A protection
How does it work?
Nanoscale ZnO absorbs and scatters UV-
light
Skin
High sun-protection factor
Good feeling
Protects against cancer and skin aging
Wood and polymers
Long term UV-protection
Transparency
No leaching
Stable at elevated temperature
SourceDechema / VCI
Increased outdoor lifetime of wood
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 21
22. Self-cleaning surfaces: Lotus effect
Lotus leaf Microstructures of a lotus leaf with Technical realisation of
water-repelling nanostructured the lotus effect
wax crystals Beispiel: Facade paint
Surface with lotus effect
water
dirt particles
Source: FCI
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 22
23. Cancer therapy with nanobiotechnologically
modified iron oxide nanoparticles
Application principle:
Nano-particles are absorbed specifically by the
cancer cells
Special iron oxide nano-particles are super-
heated in cancer cells by an external magnetic
field thereby killing the cancer cells
Status quo
since 2005 clinical trials for glioblastoms
(malignant brain tumors)
in 2011 this treatment has received an EU
approval for therapy use
Source: MagForce
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 23
24. Carbon Nanotubes
Strongly investigated since the beginning of the 90’s
Extraordinarily active field of research
Properties:
Applications: 6 times lighter than steel—but
Composite materials (metal, ceramic, 100 times stronger
polymer matrix) Compressive strength: 2 x
Field emission displays Kevlar
Tensile strength: 10 x steel
CNT-electronics
high electrical conductivity
Bio sensors
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 24
25. Nanotechnology in cars today…
Color dependent on
Anti-reflection coating viewing angle
(dashboard instruments)
Scratch-resistant paint
Heat-reflecting and self-
cleaning glazing
Reduced wear and tear
in the engine
Scratch resistant
coating (plastic parts)
Light-emitting diodes Dirt-repellent surfaces
(LEDs) in the headlights
Elektrochrome rear-view mirrors
Carbon Black in tires for less (darken upon receiving an
abrasion and better adhesion
electrical signal)
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 25
26. …and tomorrow
Scratches in the paintwork “heal`” by themselves with
selforganizing nanoparticles
Catalysts and nano membranes for
Distributed solar cells using better fuel cells
conformable photovoltaics
High-brightness nano-enhanced polymer displays
Carbon nanotube alloys for lighter,
tougher frames
Ceramics with improved catalysts
for reduced emissions Sensors monitoring e.g. road
conditions, vehicle’s steering
ability
Lighter, tougher tires; nanoclays to
improve tire gas barriers
Polymer composite panels for
greater stiffness and toughness
Fast-charge batteries for
hybrid cars
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 26
27. Direct benefits for insurers from nanoproducts
Damage-resistant building materials – but
loss patterns with new materials are
unknown
Stronger or more adaptive materials to
absorb crashes (e.g. automotive sector)
Wireless, nano-enabled sensors to report
defects in structural components
Pollution cleanup and prevention
Nanoenabled medical therapies
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 27
28. Table of
contents 1 Allianz and AGC&S
2 Emerging risk definition
3 What is nanotechnology and where is it used?
4 Opportunities and risks from an insurers
perspective
5 Risk assessment of nanorelated applications
6 What is needed to promote nanotechnologies in
as sustainable manner?
7 Outlook
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 28
29. The business opportunities from an insurer’s perspective
Growth sector for commercial and industrial insurance cover
Adequate insurance cover as an prerequisite for entrepreneurial activity
especially for small- and medium-sized enterprises
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 29
30. However...
Free nanoparticles
- can travel deep into the lung and reach the alveoli
- can induce inflammation and tissue damage
- can pass the blood brain barrier
- can reach the blood stream and are transported to
various organs © David B Warheit, DuPont Haskell
Laboratory
- can enter the body over various pathways
A few manufactured nanomaterials have shown toxic properties
There is a correlation of the concentration of fine and ultrafine particles in
ambient air with mortality rates found in epidemiological studies
We cannot exclude unintended long term effects on health and environment
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 30
31. …and the exposure of persons and the release of
nanoparticles into the environment will increase
Contamination of the environment, buildings etc. from sudden and
accidental releases
Increasing number of work places affected
Increasing deliberate applications in products
(Medicine, Pharma, Cosmetics etc.)
Unintended release of nanoparticles from products
during their life cycle
(use, destruction, incineration, disposal ...)
Water droplet / „Lotus“-effect
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 31
32. Why is Nanotechnology an Emerging Risk
for insurers (1)
Existing insurance covers include risks of nanotechnology.
The knowledge is incomplete in terms of emission sources and quantities,
toxicology, ecotoxicology and environmental behaviour.
Reliable standardised methods of measurement and guidelines for testing
are mostly missing.
Involvement of high number of companies from different industries incl.
subsequent processing companies.
Multiple lines of business and multiple classes of insured could see claims
Potential loss scenario resemble major product liability cases from the past.
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 32
33. …why is Nanotechnology an Emerging Risk
for insurers (2)
Regulatory uncertainties
Unclear definition and terminology
Ambiguity in risk perception - significant NGO activity and low consumer
knowledge
No loss history available
Imbalance and lack of information
Identification, monitoring and controlling of those few particles and
applications which may pose a health or environmental risk is difficult.
=> Even under an optimistic scenario it will take several years until the
“knowledge gaps” will be closed
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 33
34. Emerging Risk Update - Nanotechnology
Occupational health risks1)2)
More than 1,000 nanotechnology firms in US have fewer High Nano
than 25 people. related
Survey on occupational safety and health, University of
occupational
California: health risks for
SMEs and
- Only 46% of Nano firms have nano-specific
environmental health and safety programs (EHS).
secondary
producers…
- Nearly 30% of the companies that did require personal
protection only required dust masks.
- Confusion about the right best practice measures in
terms of nano workplace safety.
The larger the firm, the more likely it will have nano-
specific EHS in place.
1) http://www.newhavenindependent.org/index.php/archives/entry/survey_shows_confusion_on_protecting_nano_workers
2) http://www.genre.com/sharedfile/pdf/InsuranceIssues201111-en.pdf
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 34
35. Emerging risk update - Nanotechnology
EU- operational health and safety experts (OSHA)
see nanoparticles as major concern on workers Increasing risk
health. perception of
http://osha.europa.eu/en/publications/reports/TE3008390ENC_chemical_risks/view
Nanotech risks
No pending claims known but legal advisers on the part of
recommend to place nanoproducts into commerce regulatory
before insurers are able to realise and quantify bodies, lawyers
nanorisks. and research
Due to toxicity concerns industry will face tougher institutes.
product testing rules for nanoparticles in cosmetics
as of 2013 (e.g. sunscreens).
EU reforms will force food manufacturers (EU’s
novel food regulation) to state and to label if
products contain nanoparticles.
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 35
36. Potential for major exposure
Factor for consideration Manufacture Use End of life
Ability to control exposure High Medium Low
Time for impact Short or long Long Long
Potential for exposure to nanomaterials
Who/what at risk for exposure Workers Consumers Environment
Key form of exposure Free particles Fixed particles Fixed particles
Degree of regulation High Medium Low
Incentive for produce to invest in
High High Medium
countermeasures
Tens to Thousands to
Number of individuals at risk Millions
thousands millions
Possible over
Opportunity for exposure to large volumes Frequent Rare
time
Unresolved questions Fewest More Most
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 36
37. Nanotechnology risk landscape
Many voluntary data-gathering
systems but no
Regulatory Risk international nomenclature
practical guidelines
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 37
38. Nanotechnology risk landscape
Most of the products seems to be
safe
Number of risk studies is
Production Risk increasing but
no clear answers on safety
profile of nanoparticles and
Regulatory Risk nanoproducts
The more risk studies we see
the higher the (un)certainty
gets(?) – disputes among
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
Copyright Allianz SE experts can be 38 basis for
the
27
future claims
39. Nanotechnology risk landscape
Highest impact on the overall risk,
due to the lack of
qualified hazard and exposure
data
Perceptual Risk
strong legal framework
harmonised public risk
communication (risk-benefit
approach)
Production Risk
Regulatory Risk
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 39
40. Nanotechnology headlines
Nanotechnology risks: The new asbestos?
The safety risks of nanotechnology use by the food industry What is the
could make it “the we asbestos”….
influence of the
perceptual risk
Nanofibres could be as harmful as on nano-
asbestos
Experts have said that inhaling nanofibres technology?
could be equally as damaging as breathing
asbestos.
Nanomaterials, sunscreens and cosmetics:
Small ingredients, big risks
Friends of the Earth's report “Nanomaterials, sunscreens and
cosmetics: Small ingredients, big risks" details the extensive use of
nanomaterials in 116 products, from sunscreens and anti-aging
The dangers of nanotechnology, a
creams to shampoos and toothpastes, despite preliminary scientific warning to consumers
evidence that many types of nanoparticles can be toxic. Although there is potential benefit to
consumers, nanomaterials can also pose new
threats to human health and the environment -
Nanotech-based products offer warns consumer group.
great potential but unknown risks
Some experts push cautious approach as
market keeps expanding
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 40
41. Table of
contents 1 Allianz and AGC&S
2 Emerging risk definition
3 What is nanotechnology and where is it used?
4 Opportunities and risks from an insurers
perspective
5 Risk assessment of nanorelated applications
6 What is needed to promote nanotechnologies in
as sustainable manner?
7 Outlook
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 41
42. Risk level for selected Nanomaterials
(Nano)-silver Carbon Nanotubes Carbon Black
Low Risk Medium Risk High Risk
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 42
43. Case study: (Nano)-Silver applications
Products today:
• Textiles
• Food-packaging
• Self-sterilizing medical or
consumer devices More and more products are entering the
• Washing machines market
Lack of risk data and categorization as
pesticides raise concerns
NGO calls for Samsung “Nano Silver” washing
machine recall
Perceptual Risk
Long-term experience with silver-ion devices
Seems to be a low risk for workers and
consumers
Many open questions concerning disposal of
products (environmental risk)
Production Risk
EPA (US) has regulated silver-ion-generating
applications as pesticides
but only marketing of these products is
Regulatory Risk affected
Low Risk Medium Risk High Risk Regulation based on environmental risks to be
expected
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 43
44. Case study: Carbon Nanotubes
Products today:
• Composites
• Electronic devices
Frequently compared with asbestos
Few “close-to-the-consumer” applications
(e.g. food, cosmetics, pharmaceuticals)
Perceptual Risk
Variety of production processes creates CNTs
with different properties incl. unclear toxicity
effects
Low exposure level (today)
Many safe applications (electronic devices) but
also applications with unclear effects over
Production Risk product-life-cycle
Regualtory framework for CNTs will probably
change due to material specifics
Regulatory Risk
Low Risk Medium Risk High Risk
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 44
45. P
Case study: Carbon Black
Used since decades without risk concerns
coming up
Remaining risk:
Ultra fine dust (e.g. wheel abraison)
•Car tires
•Toner pigments Cause of health complaints concerning
emissions of office machines still
Perceptual Risk unclear
High market relevancy and long time
experience in manufacturing
No evidence for specific bodily or
environmental harm at manufacturing or
disposal
Production Risk
No need for regulatory changes due to
extensive data
Regulatory Risk
Low Risk Medium Risk High Risk
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 45
46. Technical risk assessment approaches
Toxicological
perspective
Exposure Hazard
Insurance
perspective
Frequency Severity
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 46
47. Insurance scenarios
Pollution spill from a nanoparticle production facility
Nanoparticle manufacture workers develop chronic illness
Nanoparticles leach from products to accumulate in the environment
Product recall due to research findings indicating product is a hazard
Liability claims on a company, directors and officers regarding a product that was
indicated by research to be unsafe, but subsequently released to the consumer
market.
Source: Lloyds
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 47
48. Magic Nano - First Product liability claim with Nano?
Product
Aerosol sealing spray for making glass and ceramic surfaces
water- and dirt-repellant
Loss history
100 customers reported respiratory complaints
Media: “First health-related product recall of an alleged
nanotechnology consumer product”
Insured product liability event (loss amount < 1 Mio EUR,
secondary claims via social insurance agencies)
Damage & loss analysis results
No nano-sized ingredients (silicon dioxide)
Potential cause of loss: Inhalation of very fine airborne droplets
Lack of evidence base
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 48
49. Magic Nano - Lessons learned
Reputational risk
First impressions matter
Incident was a wake-up call for the whole nano community
Negative blast for a hitherto positive image of business
Recommendations
Development of standards for terminology and labeling
More transparency on use of nanomaterials and safety issues
Appropriate research activities into human health and
environmental impacts
Risk Management:
- Reputational damage exposure
- Crisis communication
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 49
50. Table of
contents 1 Allianz and AGC&S
2 Emerging risk definition
3 What is nanotechnology and where is it used?
4 Opportunities and risks from an insurers
perspective
5 Risk assessment of nanorelated applications
6 What is needed to promote
nanotechnologies in as sustainable manner?
7 Outlook
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 50
51. Risk Management process
Risk Insurance
identification
solutions
Risk avoidance provides the
financial
s sy ana ks R
Risk
i
assessment
Risk reduction, loss security to ease
prevention
(e.g. workplace safety the bump in the
i l
measures) balance sheet.
Risk handling Risk transfer (e.g. insurance)
Risk provisions
(e.g. setting up reserves)
Risk control
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 51
52. Risk categories
unknown risks
insurable risks
elusive risks
insured risks
quantifiable risks
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27©Copyright Allianz SE 52
53. Insurability of nanotechnologies
Criterion • Status quo
•
Assessability: • limited evidence base
Probability and severity of losses quantifiable • latency effects / long term exposure
•
Randomness:
Time of insured event unpredictable and • √
occurence independent of will of insured
• wide variety of applications
Mutuality • wide variety of chemical substances, sizes, surfaces
Risk community, large number of risks, • various industry segments
diversification • various sizes of clients
• sub classes of widely used materials
•
Economic feasibility
• strongly dependent on scenario
Premium commensurate with the risk
Causation
• Agent in principle analytically provable
Causal relationship between the action or
• Signature diseases?
omission of the insured and the resulting
• Knowledge gaps can lead to legal risks
damage / injury / financial loss
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 53
54. An insurer provides financial security for remaining
risks via insurance cover if:
Predictable issues are positively and
transparently handled Identify Assess
risks risks
Problematic processes/products do not enter
RM
market Cycle
Monitor & Implement
Unique or novel risks are identified early and Control measures
managed properly
Existing hazards are actively managed
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 54
55. What is needed to promote innovative technologies?
Nanotechnology: Requirement profile of different stakeholders
Manufacturer • Access to loans / equity capital • Insurances are a
• Reliable results from safety/toxicology studies precondition for access
• Information concerning safe handling of to capital markets
nanomaterial incl. measuring methods
• Risk costs can be
• Support in compiling Material Safety Data distributed onto many
Sheets (MSDS) shoulders which allows
• Binding character of toxicological results and (excessive?) risks to be
impact on regulatory framework taken
• Open communication and information on both
Consumer • Transparency via
risks and benefits stakeholder dialogues, risk
• Generally understandable risk and ingredients assessments and adequate
information via media (e.g. internet, TV) incl. risk premiums
labeling • Best available
• Convenient for consumers and independent technology for loss
test results prevention measures
• Code of practice?
Regulator • Uniform terminology
• Acknowledged measuring methods and • What is an accepted
standards risk level?
• Valid toxicological research results
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 55
56. What is needed for a sustainable development of
Nanotechnology?
Risk Management/Risk Assessment
Risk assessments across the whole product lifecycle
Reliable results from safety/toxicology studies
Information concerning safe handling of nanomaterial incl. measuring methods
Support in compiling Material Safety Data Sheets (MSDS)
Binding character of toxicological results and impact on regulatory framework
PROs: Limitations Supportive measures
+ Gives clear guidance how to - How much tests/evidence base Development of best practice
assess the risk of are required? guidelines for safe production
nanomaterials and nano-
enabled products
- Must include the whole product and handling
lifecycle Stakeholder dialogues?
- Variety of particles, production Funding of risk research
methodologies, applications
- Limitations concerning
adequate and standardised
measuring methods and
instruments
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 56
57. What is needed for a sustainable development of
Nanotechnology?
Risk communication and perception
Open communication and information on both risks and benefits
Generally understandable risk and ingredients information via media (e.g. internet, TV) incl.
labeling
Convenient for consumers and independent test results
PROs: Limitations Supportive measures
+ Understandable risk/benefit - What is a general accepted risk Stakeholder dialogues?
analyses increase the level and how to define it?
acceptance level of
nanotechnology
- Risk/benefit methodology has
to bridge the gap between
being accurate enough and
easy-to-understand
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 57
58. What is generally required to drive innovative technologies
sustainable?
Risk-/benefit How much
Stakeholder analyses for a evidence of risks
dialogues general accepted does a society
risk level need?
Moratorium
versus How much
corporate regulation is
self- needed?
responsibility
Risk assessment: Is How should a …and what
there evidence that a future best- can be the
proactive practice Risk contribution
Environmental, Social, Management of insurers?
Governance (ESG) look like?
Management signals a
better overall Risk
Management of a
company
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 58
59. Table of
contents 1 Allianz and AGC&S
2 Emerging risk definition
3 What is nanotechnology and where is it used?
4 Opportunities and risks from an insurers
perspective
5 Risk assessment of nanorelated applications
6 What is needed to promote nanotechnologies in
as sustainable manner?
7 Outlook
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 59
60. The Outlook
Sustainable exploitation of nanotechnologies will lead to economic and
technical progress that are of major importance to the global economy.
Dedicated research on risks, high-quality risk management and continuous
dialogue will lay foundation for positive public take-up of nanotech.
Positive stewardship, complemented by responsible insurance will support
the sustainable future of nanotech developments.
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 60
61. Thank you for
your
attention!
61
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 61
62. Disclaimer
These assessments are, as always, subject to the disclaimer provided below.
Cautionary Note Regarding Forward-Looking Statements
The statements contained herein may include statements of future levels, (vi) the extent of credit defaults, (vii) interest rate levels, (viii) currency
expectations and other forward-looking statements that are based exchange rates including the Euro/U.S. Dollar exchange rate, (ix) changing
on management’s current views and assumptions and involve known levels of competition, (x) changes in laws and regulations, including
and unknown risks and uncertainties that could cause actual results, monetary convergence and the European Monetary Union, (xi) changes in
performance or events to differ materially from those expressed or the policies of central banks and/or foreign governments, (xii) the impact of
implied in such statements. In addition to statements which are forward- acquisitions, including related integration issues, (xiii) reorganization
looking by reason of context, the words “may”, “will”, “should”, “expects”, measures, and (xiv) general competitive factors, in each case on a local,
“plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, regional, national and/or global basis. Many of these factors may be more
“potential”, or “continue” and similar expressions identify forward-looking likely to occur, or more pronounced, as a result of terrorist activities and their
statements. Actual results, performance or events may differ materially consequences.
from those in such statements due to, without limitation, (i) general economic
conditions, including in particular economic conditions in the Allianz Group’s
core business and core markets, (ii) performance of financial markets,
including emerging markets, and including market volatility, liquidity and
credit events (iii) the frequency and severity of insured loss events,
including from natural catastrophes and including the development of loss No duty to update.
expenses, (iv) mortality and morbidity levels and trends, (v) persistency The company assumes no obligation to update any
information contained herein.
© November 2012, Milano, Role of Insurance for Innovative Technologies: Nanotechnology
27
Copyright Allianz SE 62